All Stories

  1. Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study

    Article • Expert Opinion on Drug Delivery, December 2017, Taylor & Francis

    Dr. Barry Singer

  2. The role of natalizumab in the treatment of multiple sclerosis: benefits and risks

    Article • Therapeutic Advances in Neurological Disorders, June 2017, SAGE Publications

    Dr. Barry Singer

  3. Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies

    Article • Seminars in Neurology, April 2016, Thieme Publishing Group

    Dr. Barry Singer